Tripos Directors Reaffirm Plan to Explore M&A, Divestiture | GenomeWeb

NEW YORK, May 18 (GenomeWeb News) - Tripos' board of directors have "reaffirmed [their] commitment" to explore options for spurring growth, including selling or merging the firm, going private, or separating its informatics and research businesses.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.